Soller leaves UCSF to consult full-time; Aker hires former Clavis Pharma scientists for krill R&D; Perrigo adds nutritional regulatory manager; USP veteran Sharaf joins AHPA; ex-mayor of Los Angeles advises Herbalife; FDA’s Plaisier earns permanent ORA appointment; more People In Brief.

Soller leaves UCSF to consult full-time; Aker hires former Clavis Pharma scientists for krill R&D; Perrigo adds nutritional regulatory manager; USP veteran Sharaf joins AHPA; ex-mayor of Los Angeles advises Herbalife; FDA’s Plaisier earns permanent ORA appointment; more People In Brief.

In Vivo introduces a new quarterly feature, a statistical review compiled from our Strategic Transactions database. In this edition, we include financings by type (IPO, private placement etc.); financings by sector (surgical equipment, implantable devices, etc.); alliances by therapeutic category (cardiovascular, orthopedic, etc.); alliances by industry segment (biomaterials, monitoring equipment, etc. ); for three separate industries: medical devices, in vitro diagnostics, and pharmaceuticals/biotechnology.